Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 4 de 4
Filtrar
Más filtros




Base de datos
Asunto de la revista
Intervalo de año de publicación
1.
Int J Clin Pediatr Dent ; 13(2): 150-154, 2020.
Artículo en Inglés | MEDLINE | ID: mdl-32742092

RESUMEN

AIM: To analyze the comparative change in pretreatment and posttreatment La*b* values of color in initial nonpitted white spot lesions of fluorosed teeth after resin infiltration with DMG-Icon spectrophotometrically with VITA easy shade. MATERIALS AND METHODS: A total of 30 maxillary and mandibular permanent anterior teeth with mild, nonpitted white spot lesions (atleast one) of fluorosis [till grade IV of Thylstrup and Fejerskov (TF) index] in patients between 6 years and 14 years of age were included in the present study. Shade of selected tooth and its white spot lesion area was recorded using VITA 3D shade guide, both pre and postoperatively, i.e., after application of DMG Icon. This was followed by recording the change in corresponding La*b* values of tooth shade and white spot lesion spectrophotometrically using VITA Easy Shade. Results obtained were analyzed statistically. RESULTS: ΔE value of color change was found to be less than 3.7 in most of samples after resin infiltration and esthetically color change to naked eye was statistically significant (p value < 0.00001) postoperatively. CONCLUSION: Resin infiltration with DMG Icon can improve the color of non-cavitated white spot lesions. The esthetic effect of this treatment was evident immediately after treatment. Moreover, no cavitation occurred after etching, even when the surface layer had been eroded completely. CLINICAL SIGNIFICANCE: Achievement of esthetic results without loss of tooth structure and postoperative sensitivity. HOW TO CITE THIS ARTICLE: Dogra S, Goyal V, Gupta A, et al. Spectrophotometric Evaluation of Color Change in Tooth Enamel Defects Using Resin Infiltrate: An In Vivo Study. Int J Clin Pediatr Dent 2020;13(2):150-154.

2.
Indian J Dent Res ; 27(3): 249-55, 2016.
Artículo en Inglés | MEDLINE | ID: mdl-27411652

RESUMEN

BACKGROUND: Periodontal attachment loss could be an earlier indicator or a possible risk factor of dentine hypersensitivity (DH). Thus, there is a need for diagnosing this condition both by questionnaire and by clinical examination before rendering both home care and in-office treatment modalities. AIMS: To investigate the relationship between various demographic factors and DH and to detect the percentage of patients using desensitizing agents. MATERIALS AND METHODS: In this cross-sectional study, 2051 patients were evaluated till the required sample size of 1000 patients was achieved who were evaluated both by questionnaire and clinical test. Association between DH clinical attachment level and apparent recession was established. RESULTS: This study found that the prevalence of dentine hypersensitivity in chronic periodontitis patients was 37.2% according to questionnaire and 47.8% according to the results of clinical test. Various demographic factors were found to affect dentine hypersensitivity such as age, gender, education, diet, and locality. CONCLUSION: The prevalence of dentine hypersensitivity in chronic periodontitis patients was 37.2% according to questionnaire and 47.8% according to the results of clinical test. Periodontal attachment loss could be an earlier indicator or a possible risk factor of DH. Only 14.36% of the patients with sensitive teeth used desensitizing paste. This could be due to the fact that either the patients did not consider the condition bad enough to warrant treatment or it was not being diagnosed.


Asunto(s)
Periodontitis Crónica/epidemiología , Sensibilidad de la Dentina/epidemiología , Adulto , Anciano , Estudios Transversales , Femenino , Humanos , India/epidemiología , Masculino , Persona de Mediana Edad , Prevalencia , Encuestas y Cuestionarios
3.
J Nat Sci Biol Med ; 4(1): 3-7, 2013 Jan.
Artículo en Inglés | MEDLINE | ID: mdl-23633828

RESUMEN

Various modalities of treatment are available for different dental diseases, but the major drawback of these conventional drug therapies is the numerous side effects associated with their use. This has led to renewed interest in the discovery of novel anti-infective natural compounds derived from plants. Plants have been the major source of medicine since the time immemorial. Turmeric has been attributed a number of medicinal properties in the traditional system of medicine. The objective of this article is to review the efficacy of turmeric herb in maintenance of oral health, in particular, and overall health, in general. Turmeric, a rhizome of Curcuma longa, is a herb known for its medicinal properties and is a more acceptable and viable option for a common man. It has proven properties like anti-inflammatory, antioxidant, antimicrobial, hepatoprotective, immunostimulant, antiseptic, and antimutagenic. Due to these properties, it is quite useful in dentistry as well. It has a role in the treatment of periodontal diseases and oral cancers. Turmeric can also be used as a pit and fissure sealant, mouth wash, and subgingival irrigant in different preparations. It can also be used as a component in local drug delivery system in gel form.

4.
Int J Gynaecol Obstet ; 106(1): 23-6, 2009 Jul.
Artículo en Inglés | MEDLINE | ID: mdl-19375704

RESUMEN

OBJECTIVE: To compare the efficacy and safety of oral misoprostol with intracervical prostaglandin E2 (PGE2) gel for the active management of premature rupture of membranes (PROM) at term. METHODS: Women with pregnancies between 37 and 42 weeks presenting with PROM at term and a Bishop score of 5 or less were randomly assigned to receive either a 4-hourly oral dose of 50 microg of misoprostol up to a maximum of 3 doses or 2 applications of intracervical PGE2 gel at a 6-hour interval. Oxytocin was given if labor had not started after 12 hours. RESULTS: Twenty women in the misoprostol group (n=31) delivered within 12 hours compared with 5 in the PGE2 group (n=30) (P<0.001). The induction-to-delivery interval in the misoprostol group was shorter than in the PGE2 gel group (615 min vs 1070 min; P<0.001). The mode of delivery was comparable between the 2 groups (P=0.821). Abnormalities in uterine contractions and neonatal outcomes were also comparable. The requirement for oxytocin was lower and patient satisfaction was better in the misoprostol group. CONCLUSION: Oral misoprostol is a safe and efficacious alternative to intracervical PGE2 gel in the active management of PROM at term.


Asunto(s)
Dinoprostona/uso terapéutico , Trabajo de Parto Inducido/métodos , Misoprostol/uso terapéutico , Oxitócicos/uso terapéutico , Administración Intravaginal , Administración Oral , Adulto , Dinoprostona/administración & dosificación , Dinoprostona/efectos adversos , Femenino , Rotura Prematura de Membranas Fetales/tratamiento farmacológico , Geles , Humanos , Misoprostol/administración & dosificación , Misoprostol/efectos adversos , Oxitócicos/administración & dosificación , Oxitócicos/efectos adversos , Satisfacción del Paciente , Embarazo , Resultado del Embarazo , Estudios Prospectivos , Factores de Tiempo , Contracción Uterina/efectos de los fármacos , Adulto Joven
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA